Takeda Pharmaceutical Company Limited
4502
Κατάταξη σε μετοχές
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Τιμή μετοχής
$40.45
Κεφαλαιοποίηση
$64.36B
Αλλαγή (1 ημέρα)
1.19%
Αλλαγή (1 έτος)
43.11%
Χώρα
JP
Εμπόριο Takeda Pharmaceutical Company Limited (4502)
Κατηγορία
Healthcare
Ιστορικό τιμής μετοχής για την Takeda Pharmaceutical Company Limited (4502)
Υψηλότερη τιμή κλεισίματος: $38.84 στις 2026-10-01
Χαμηλότερη τιμή κλεισίματος: $15.37 στις 1990-01-01
Χαμηλότερη τιμή κλεισίματος: $15.37 στις 1990-01-01
Ιστορικό τιμής μετοχής της Takeda Pharmaceutical Company Limited από 1990 έως 2026
Ετήσια απόδοση τιμής μετοχής
| Έτος | Απόδοση |
|---|---|
| 2026 (TTM) | 16.58% |
| 2025 | 9.81% |
| 2024 | -4.74% |
| 2023 | -6.93% |
| 2022 | 10.67% |
| 2021 | -25.73% |
| 2020 | -8.85% |
| 2019 | 17.44% |
| 2018 | -38.14% |
| 2017 | 35.62% |
| 2016 | -15.67% |
| 2015 | 15.94% |
| 2014 | -13.88% |
| 2013 | 6.22% |
| 2012 | 10.14% |
| 2011 | -12.31% |
| 2010 | 13.40% |
| 2009 | -15.52% |
| 2008 | -16.70% |
| 2007 | -10.91% |
| 2006 | 20.85% |
| 2005 | 12.27% |
| 2004 | 25.62% |
| 2003 | -3.39% |
| 2002 | -8.53% |
| 2001 | -25.89% |
| 2000 | 8.44% |
| 1999 | 100.05% |
| 1998 | 14.68% |
| 1997 | 57.21% |
| 1996 | 45.92% |
| 1995 | 33.20% |
| 1994 | 4.32% |
| 1993 | -8.10% |
| 1992 | -2.51% |
| 1991 | -23.26% |
| 1990 | 0.00% |
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Τιμή μετοχής | Μεταβολή 1Έτ% | Χώρα |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $163.40 | 22.20% |
DE
|
|
| $225.72 | 31.81% |
CH
|
|
| $18.43 | -4.03% |
IN
|
|
| $6.89 | -24.78% |
CN
|
